Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

2026 Medicare Physician Fee Schedule Proposed Rule Released

From the College  |  July 20, 2025

The proposed rule includes several proposals related to Medicare physician payment and the Quality Payment Program. Read more about the provisions the ACR will address during the comment period.

Connect with Your Lawmakers During the August Recess

From the College  |  July 19, 2025

August offers an opportunity to engage with your elected officials in your state or district. Lawmakers will be considering appropriations bills when they return in September—help make sure the needs of the rheumatology community are top of mind.

Transform Your Rheumatology Practice at the 2025 Practice Innovation Summit

From the College  |  July 19, 2025

The inaugural event, to be held before ACR Convergence, will offer actionable strategies and expert insights to build a smarter, stronger and more financially sustainable practice in today’s rapidly evolving healthcare landscape.

ACR Garners Major Media Attention Following Response to Proposed 2026 Physician Fee Schedule

From the College  |  July 18, 2025

The ACR’s press release expressed disappointment about the proposed rule not going far enough to fix Medicare payment for physicians. Substantial media coverage of the response resulted in a combined reach of over 6.1 million people, amplifying the ACR’s voice and advocacy efforts.

ACR Responds to Cigna Downcoding of Evaluation & Management Codes

From the College  |  July 18, 2025

The ACR recently sent a letter to Cigna opposing its new policy, which would result in downcoding of level 4 and 5 evaluation and management claims.

Featured Member Resource: ACR Coding Lunch & Learns

From the College  |  July 18, 2025

The ACR offers a variety of coding-focused Lunch-and-Learn sessions designed to help physicians and their staff stay current with evolving healthcare regulations, coding updates and billing practices.

Finding the Panacea

Jason Liebowitz, MD, FACR  |  July 16, 2025

Janus kinase (JAK) inhibitors, biologics and more—Dr. Laura Coates discussed the management of PsA, providing insights into the current research and when clinicians may want to consider prescribing specific medications.

FDA Approves Ustekinumab-stba for All Forms & Dosages as Its Reference Product

Michele B. Kaufman, PharmD, BCGP  |  July 16, 2025

Ustekinumab-stba (Steqeyma) now has FDA approval for all forms and dosages of its reference product, ustekinumab (Stelara), including a subcutaneous injection to treat pediatric patients with plaque psoriasis or psoriatic arthritis.

Rheum for Everyone, Superheroes, Secret Identities & You: Episode 22 (video)

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  July 15, 2025

In this episode, Dr. Kumar talks about the fascinating and intriguing secret lives of rheumatologists—real life superheroes.

B Original

Jason Liebowitz, MD, FACR  |  July 15, 2025

Experts discussed how aspects of the immune system other than B cells play a role in lupus, including mitochondria in red blood cells, proteins present in urine and more.

  • 1
  • 2
  • 3
  • …
  • 823
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences